Acción USNU U.S. NEUROSURGICAL HOLDINGS, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas U.S. NeuroSurgical Holdings, Inc.

Acciones

USNU

US90336K1016

Mercado cerrado - OTC Markets
Otros sitios de cotización
 17:26:19 29/04/2024 		Varia. Cinco días. Varia. 1 de enero.
0,72 USD +1,41 % Gráfico intradía de U.S. NeuroSurgical Holdings, Inc. +1,41 % +60,00 %
05/04 U.S. NeuroSurgical Holdings, Inc. presenta los resultados del ejercicio finalizado el 31 de diciembre de 2023 CI
2023 U.S. NeuroSurgical Holdings, Inc. presenta los resultados del tercer trimestre y de los nueve meses finalizados el 30 de septiembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
U.S. NeuroSurgical Holdings, Inc. announced that it expects to receive $2 million in funding
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
U.S. NEUROSURGICAL HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)
U.S. NeuroSurgical Holdings, Inc. Appoints William St. Lawrence as a Non-Executive Director
U.S. NEUROSURGICAL HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
U.S. NEUROSURGICAL HOLDINGS, INC. : Changes in Registrant's Certifying Accountant (form 8-K)
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)
U.S. NEUROSURGICAL HOLDINGS, INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
U.S. NEUROSURGICAL HOLDINGS, INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations.
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
U.S. NEUROSURGICAL HOLDINGS, INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción USNU
  4. Noticias U.S. NeuroSurgical Holdings, Inc.
  5. Otros idiomas